Economics

This channel highlights factors that impact hospital and healthcare economics and revenue. This includes news on healthcare policies, reimbursement, marketing, business plans, mergers and acquisitions, supply chain, salaries, staffing, and the implementation of a cost-effective environment for patients and providers.

Can lower spending improve heathcare?

The answer, according to a Bloomberg Businessweek article, is a resounding yes. Writer Charles Kenny argues that the path to improved health lies in keeping patients out of doctors’ offices and bolsters his assertion with some fairly compelling insights.

Growth to return to interventional x-ray equipment market

The outlook for the U.S. interventional x-ray equipment market seems to be reverting back to positive levels as of the end of 2012, following three years of contraction in the interventional radiology (IR) and interventional cardiology (IC) segments, according to a report from market research firm Frost & Sullivan.

Disease incidence, treatment fuel healthcare spending

The rise in healthcare expenditures, particularly in the case of Medicare spending, since 1990 is primarily due to rising treatment prevalence, representing a shift from pre-1990 growth that was spurred by growing incomes, spreading insurance coverage and technological change, according to a study published in the May issue of Health Affairs.

Healthcare spending projections may overstate next-decade spending by $770B

To paraphrase Mark Twain, the reports of out-of-control healthcare spending growth are greatly exaggerated. That’s the conclusion reached by an analysis of financial trends published in the May issue of Health Affairs that found public healthcare spending over the next decade could be as much as $770 billion less than predicted.

Primary care physician shortfall to grow to 50,000 by 2025

As healthcare reform expands access to care, 30 million people will become covered by 2014, requiring more resources for primary health care training, according to a report from American Medical News.

Coverage with evidence development: The path forward

Coverage with evidence development, a provisional reimbursement strategy that provides coverage for promising new technologies under the condition that providers collect clinical data, has been touted as a strategy to boost clinical evidence and curb unnecessary healthcare costs. However, much room for improvement remains, and was outlined in a viewpoint published May 6 in JAMA Internal Medicine.

Model estimates treatment revenue offsets most costs of free lung cancer screening

As CT lung cancer screening wallows in the limbo of lack of reimbursement, pioneers are developing strategies to deliver screening to all patients. Lahey Hospital & Medical Center detailed its success with a free lung cancer screening program in an article in the May issue of Journal of the American College of Radiology.

The New Economics of Radiation Oncology

Radiation oncology seems to have a massive target on its collective back as the cancer treatment costs face increasing scrutiny.

Around the web

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.

The newly cleared offering, AutoChamber, was designed with opportunistic screening in mind. It can evaluate many different kinds of CT images, including those originally gathered to screen patients for lung cancer. 

Trimed Popup
Trimed Popup